Comparing blood glucose management methods in diabetic patients after pancreas surgery
Official title: Comparison of the Efficacy and Satisfaction of Blood Glucose Management Between Continuous Glucose Monitoring Versus Traditional Self-blood Glucose Measurement in Diabetic Patients After Pancreatectomy : A Randomized Controlled Open Labeled Trial
Run by Seoul National University Hospital · NCT05149625 · Data updated 2026-11-12
This study is testing whether continuous glucose monitoring or traditional blood sugar checks work better and make diabetic patients happier after they've had pancreas surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 19 Years and up |
| Sex | All |
| Enrollment | 172 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 1 site (Seoul) |
| Status | Recruiting |
| Started | November 27, 2022 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | April 12, 2023 |
| Trial ID | NCT05149625 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 19 years old with a history of diabetes who have undergone subtotal or total pancreatectomy.
✕Probably not a fit
Patients with prior experience using continuous glucose monitoring devices or those with serious systemic diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study compares the effectiveness and patient satisfaction of continuous glucose monitoring versus traditional self-blood glucose measurement in diabetic patients who have undergone pancreatectomy. Patients will be randomly assigned to one of the two monitoring methods after a glucose tolerance test conducted one week post-surgery. Over a three-month period, outcomes such as HbA1c levels, hypoglycemic events, and overall satisfaction will be evaluated to determine which method provides better management of blood glucose levels.
Why it matters
Potential benefit: If successful, this study could lead to improved blood glucose management strategies for diabetic patients post-pancreatectomy.
How similar studies have gone: Previous studies have shown promising results with continuous glucose monitoring in diabetic management, suggesting this approach may be effective.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over 19 years of age * Preoperative diabetes history * Patients who underwent subtotal or total pancreatectomy * Patients who were diagnosed with diabetes mellitus in the evaluation of endocrine function test on the 7th day after pancreaticoduodenectomy, central pancreatectomy, or distal pancreatectomy Exclusion Criteria: * Patients who have used continuous blood glucose measurement device more than once before. * Elderly patients who are not accustomed to using the smartphone applications * Serious systemic diseases that can affect diabetes (chronic kidney disease, heart failure, decompensated liver cirrhosis, etc.) * Steroid user during the study period * Major medical or psychiatric condition that will affect response to treatment
Where it's running
-
Department of Surgery, Seoul National University College of Medicine
Seoul, South Korea Recruiting
Study contacts
- Principal investigator: Jin-Young Jang, Dr — Seoul National University Hospital
- Study coordinator: Jin-Young Jang, Dr
- Email: jangjy4@gmail.com
- Phone: +82-02-2072-2194
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventing lower limb artery disease in adults with diabetes using a risk-prediction model and HAPA-based nursing
A risk-prediction model is tested in adults with type 2 diabetes to see if a nursing plan based on the HAPA model can reduce peripheral artery disease in the legs.
-
DiaFootCare: a mobile app to help adults with diabetic foot ulcers manage self-care in Oman
A mobile app called DiaFootCare will be tested to see if it helps adults with diabetic foot ulcers in Oman take better care of themselves and improve healing compared with usual care.
-
Predictive CGM with App for people with type 1 or insulin-treated type 2 diabetes
This study tests whether using the Accu-Chek SmartGuide CGM with its Predict App can reduce fear of hypoglycemia and improve related behaviors and confidence in adults with type 1 or insulin-treated type 2 diabetes.
-
SugarVita 2.0: a 12-week digital game for adults with type 2 diabetes
This 12-week pilot tests SugarVita 2.0, a serious digital game, to see if it helps adults with type 2 diabetes manage their condition and feel more confident.
-
Linking social care with healthcare to help manage chronic diseases
This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.
-
Transcutaneous and topical photobiomodulation for diabetic foot ulcers
This phase 2 trial tests whether combining transcutaneous and topical photobiomodulation helps heal foot ulcers in adults with diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.